Publikationen 2023 - in Bearbeitung
Publikationen 2022
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol. 2022 Mar;60(3):332-418. German. doi: 10.1055/a-1713-3941. Epub 2022 Mar 9. PMID: 35263784. | Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators |
Die wichtigsten Änderungen der aktualisierten S3-Leitlinie Morbus Crohn der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) im Überblick. Z Gastroenterol. 2022 Mar;60(3):295-296. German. doi: 10.1055/a-1713-4177. Epub 2022 Mar 9. PMID: 35263781. | Stallmach A, Sturm A. |
Leitlinienreport der aktualisierten S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol. 2022 Mar;60(3):e228-e235. German. doi: 10.1055/a-1713-4138. Epub 2022 Mar 9. PMID: 35263779 | Lorenz P, Stallmach A, Sturm A, Jansen PL. |
Bakterielle hepatobiliäre Infektione: Erregerspektrum, antimikrobielle Resistenzentwicklung und aktuelle Therapiekonzepte. Internist (Berl). 2022 Apr;63(4):349-366. German. doi: 10.1007/s00108-022-01277-0. Epub 2022 Mar 3. PMID: 35238985. | Bruns T, Stallmach A |
Detection of Liver Dysfunction Using a Wearable Electronic Nose System Based on Semiconductor Metal Oxide Sensors. Biosensors (Basel). 2022 Jan 26;12(2):70. doi22.04.2022 10.3390/bios12020070 | Voss A, Schroeder R, Schulz S, Haueisen J, Vogler S, Horn P, Stallmach A, Reuken P. |
Transfer of Frozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials. 2022 Feb 22;23(1):173. doi: 10.1186/s13063-022-06095-1. PMID: 35193638; PMCID: PMC8861997. | Stallmach A, Grunert P, Stallhofer J, Löffler B, Baier M, Rödel J, Kiehntopf M, Neugebauer S, Pieper DH, Junca H, Tannapfel A, Merkel U, Schumacher U, Breternitz-Gruhne M, Heller T, Schauer A, Hartmann M, Steube A |
Meta-analysis of aspirin-guided therapy of colorectal cancer. J Cancer Res Clin Oncol. 2022 Feb 16. doi:10.1007/s00432-022-03942-1. Epub ahead of print. PMID: 35171329. | Mädge JC, Stallmach A, Kleebusch L, Schlattmann P |
Chronisch-entzündliche Darmerkrankungen in der COVID-Pandemie: Manifestationen und Management [Inflammatory bowel disease during the COVID-19 pandemic: manifestations and management]. Z Gastroenterol. 2022 Feb 11. German. doi: 10.1055/a-1744-6697. Epub ahead of print. PMID: 35148564. |
Stallmach A, Reuken PA, Grunert P, Teich N. |
Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis. Dig Dis. 2022 Jan 31. doi: 10.1159/000522259. Epub ahead of print. PMID: 35100589. | Quickert S, Würstle S, Reuken PA, Hagel S, Schneider J, Schmid RM, Neugebauer S, Stallmach A, Bruns T. |
Clinical predictors for a complicated course of disease in an inception cohort of patients with ulcerative colitis: results from the prospective, observational EPICOL study. Int J Colorectal Dis. 2022 Feb;37(2):485-493. doi: 10.1007/s00384-022-04098-7. Epub 2022 Jan 27. PMID: 35084534; PMCID: PMC8803753 | Schmidt C, Bokemeyer B, Lügering A, Bettenworth D, Teich N, Fischer I, Hammer L, Kolterer S, Rath S, Stallmach A; EPICOL Study Group |
ROS-Sensitive Polymer Micelles for Selective Degradation in Primary Human Monocytes from Patients with Active IBD. Macromol Biosci. 2022 Apr;22(4):e2100482. doi: 10.1002/mabi.202100482. Epub 2022 Feb 3. PMID: 35068059. |
Gardey E, Sobotta FH, Quickert S, Bruns T, Brendel JC, Stallmach A. |
SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease. Z Gastroenterol. 2022 Jan;60(1):77-80. English. doi: 10.1055/a-1710-3861. Epub 2022 Jan 18. PMID: 35042256. | Elkharsawi A, Arnim UV, Schmelz R, Sander C, Stallmach A, Teich N, Walldorf J, Reuken PA. |
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. Clin Transl Gastroenterol. 2022 Jan 13;13(1):e00450. doi: 10.14309/ctg.0000000000000450. PMID: 35029158; PMCID: PMC8806373. | Stallhofer J, Veith L, Diegelmann J, Probst P, Brand S, Schnitzler F, Olszak T, Török H, Mayerle J, Stallmach A, Beigel F |
Comparison of fatigue, cognitive dysfunction and psychological disorders in post-COVID patients and patients after sepsis: is there a specific constellation? Infection. 2022 Jan 7:1–9. doi: 10.1007/s15010-021-01733-3. Epub ahead of print. PMID: 34997542; PMCID: PMC8741139. | Stallmach A, Kesselmeier M, Bauer M, Gramlich J, Finke K, Fischer A, Fleischmann-Struzek C, Heutelbeck A, Katzer K, Mutschke S, Pletz MW, Quickert S, Reinhart K, Stallmach Z, Walter M, Scherag A, Reuken PA |
T Cell Response After SARS-CoV-2 Vaccination in Immunocompromised Patients with Inflammatory Bowel Disease. J Crohns Colitis. 2022 Feb 23;16(2):251-258. doi: 10.1093/ecco-jcc/jjab147. PMID: 34379729; PMCID: PMC8385945. |
Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A. |
Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff. Transbound Emerg Dis. 2022 Mar;69(2):720-730. doi: 10.1111/tbed.14041. Epub 2021 Mar 9. PMID: 33605549; PMCID: PMC8014017. |
Bahrs C, Kimmig A, Weis S, Ankert J, Hagel S, Maschmann J, Stallmach A, Steiner A, Bauer M, Behringer W, Baier M, Kesselmeier M, Richert C, Zepf F, Walter M, Scherag A, Kiehntopf M, Löffler B, Pletz MW. |
Soluble mannose receptor CD206 and von Willebrand Factor are early biomarkers to identify patients at risk for severe or necrotizing acute pancreatitis. Journal of Intensive Care, in press | Philipp Reuken, Jonathan Brozat, Stefanie Quickert, Oluwatomi Ibidapo-Obe, Johanna Reißing, Anika Franz, Sven Stengel, Ulf Teichgräber, Michael Kiehntopf, Christian Trautwein, Andreas Stallmach, Alexander Koch, Tony Bruns |
Apparative Diagnostik bei Post-COVID. Information und Nutzen für therapierelevante Befunde. Deutsches Ärzteblatt, in press | Philipp A. Reuken, Marcus Franz, Benjamin Giszas, Jutta Bleidorn, Tobias Rachow, Andreas Stallmach |
Mobile Primary Healthcare for post-COVID Patients in Rural Areas: a Proof-of-Concept Study. Infection, in press | A. Stallmach, K. Katzer, B. Besteher, K. Finke, B. Giszas, Y. Gremme, R. A. Hamdan, K. Lehmann-Pohl, M. Legen, J.-C. Lewejohann, M. Machnik, M. Moshmosh Alsabbagh, L. Nardini, C. Puta, Z. Stallmach, P. A. Reuken |
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterol J. 2022 May;10(4):409-424. doi: 10.1002/ueg2.12232 | Brozat JF, Hanses F, Haelberger M, Stecher M, Dreher M, Tometten L, Ruethrich MM, Vehreschild JJ, Trautwein C, Borgmann S, Vehreschild MJGT, Jakob CEM, Stallmach A, Wille K, Hellwig K, Isberner N, Reuken PA, Geisler F, Nattermann J, Bruns T; LEOSS study group. |
Post-COVID-19 condition is not only a question of persistent symptoms – structured screening including health related quality of life reveals two separate clusters of post-COVID, Infection, in press | Giszas B, Trommer S, Schüßler N, Rodewald A, Besteher B, Bleidorn J, Dickmann P, Finke K, Katzer K, Lehmann-Pohl K, Lemhöfer C, Pletz M, Puta C, Quickert S, Walter M, Stallmach A, Reuken PA |
Monoclonal SARS-CoV-2 Antibodies in Pregnancy-a Case Series. Dtsch Arztebl Int. 2022 Feb 18;119(7):113-114 | Zöllkau J, Reuken PA, Schleußner E, Groten T. |
The Patient's Point of View: COVID-19 and Neuroendocrine Tumor Disease. Cancers (Basel). 2022 Jan 26;14(3):613. doi: 10.3390/cancers14030613 | Krug S, Khosravian M, Weissbach J, George K, Damm M, Garbe J, Walldorf J, Reuken PA, Amin T, Siebenhüner A, Rosendahl J, Gress TM, Michl P, Schrader J, Rinke A |
Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022 Apr;76(4):959-974. | de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C; for the Baveno VII Faculty. |
EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol . 2022 May;76(5):1151-1184. doi: 10.1016/j.jhep.2021.09.003 | Erica Villa, Marcello Bianchini, Annabel Blasi, Alban Denys, Edoardo G Giannini, Andrea de Gottardi, Ton Lisman, Emmanuelle de Raucourt, Cristina Ripoll, Pierre-Emmanuel Rautou |
Mineralocorticoid receptors in non-alcoholic fatty liver disease. Br J Pharmacol 2022 Jul;179(13):3165-3177. doi: 10.1111/bph.15784 | Schreier B, Zipprich A, Uhlenhaut H, Gekle M. |
Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndromeGut. 2022 Aug;71(8):1567-1576. doi: 10.1136/gutjnl-2021-325181 | Bojarski C, Tangermann P, Barmeyer C, Buchkremer J, Kiesslich R, Ellrichmann M, Schreiber S, Schmidt C, Stallmach A, Roehle R, Loddenkemper C, Daum S, Siegmund B, Schumann M, Ullrich R |
Mobile Post-COVID Units: A Win-Win Proposition? Journal of Health Care Communications, in press | Reuken, PA, Stallmach A |
Infliximab in the treatment of patients with severe COVID-19 (INFLIXCOVID): protocol for a randomised, controlled, multicentre, open label phase II clinical study. Trials, in press | Sina M Coldewey; Charles Neu; Frank Bloos; Philipp Baumbach; Ulrike Schumacher; Michael Bauer; Philipp Reuken; Andreas Stallmach |
Graft function and health status in renal transplant recipients hospitalized for COVID-19: a single center case series. J Nephrol 2022 | Giszas B*, Ruhe J*, Schlosser M, Reuken PA, John-Kroegel U, Stallmach A*, Wolf G* |
Role of IQ Motif-Containing GTPase-Activating Proteins in Hepatocellular Carcinoma. Front Oncol. 2022 Jun 16;12:920652. doi: 10.3389/fonc.2022.920652. eCollection 2022 | Dai Q, Ain Q, Rooney M, Song F, Zipprich A. |
Addendum zur S2k-Leitlinie Gastrointestinale Blutungen der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS). Z Gastroenterol. 2022 Jul;60(7):1139-1145. doi: 10.1055/a-1788-3501. Epub 2022 Jul 11 | Götz M, Biecker E, Dechêne A, Schilling D, Zipprich A, Trebicka J |
The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation. Mol Med. 2022 Jul 30;28(1):84. doi: 10.1186/s10020-022-00510-8 | Beyer D, Hoff J, Sommerfeld O, Zipprich A, Gaßler N, Press AT |
SEAL: why was this approach not effective? J Hepatol. 2022 Aug 16;S0168-8278(22)02997-X. doi: 10.1016/j.jhep.2022.07.031. Online ahead of print | Ripoll C, Bleidorn J, Zipprich A. |
Increased accuracy of FNA - based cytological diagnosis of pancreatic lesions by use of an ethanol-based fixative system: a STROBE compliant study. Medicine.(Baltimore) 2022 Sep 9;101(36):e30449. doi: 10.1097/MD.0000000000030449.PMID: 36086724 | M. Bürger, A. Besser, I. Petersen, A. Stallmach, C. Schmidt |
Adenoma detection rate using narrow-band imaging is inferior to high-definition white light colonoscopy in screening and surveillance colonoscopies in daily clinical care: A randomized controlled trial. Medicine (Baltimore). 2022 Aug 12;101(32):e29858. doi: 10.1097/MD.0000000000029858, PMID: 3596007 | Bürger M, Weber M, Petersen I, Stallmach A, Schmidt C |
Fäkaler Mikrobiomtransfer – Indikationen, Risiken und Chancen. Inn Med (Heidelb) 2022 Oct;63(10):1036-1042. doi: 10.1007/s00108-022-01399-5. Epub 2022 Sep 2. | Stallmach A, Steube A, Stallhofer J, Grunert PC, Merkel U, Hartmann M |
Gastrointestinal Infections and the Risk of Inflammatory Bowel Disease in Twins and Siblings: Evidence Against the Hygiene Hypothesis. Dig Dis Sci.2022 Oct;67(10):4960-4961. doi: 10.1007/s10620-022-07670-x. Epub 2022 Aug 24. PMID: 36002673 PMCID: PMC9515034 | Teich N, Stallmach A, Bruns T |
SER-109: oral microbiome therapy for recurrent Clostridioides difficile infections : SER-109 versus Placebo in the Treatment of Adults with Recurrent Clostridium Difficile Infection (ECOSPOR III). Inn Med (Heidelb).2022 Jul;63(7):805-807. doi: 10.1007/s00108-022-01346-4. Epub 2022 May 17. PMID: 35925263 | Stallmach A, Nitschmann S |
Larger gray matter volumes in neuropsychiatric long-COVID syndrome. Psychiatry Research,2022 Nov;317:114836. doi: 10.1016/j.psychres.2022.114836. Epub 2022 Sep 6. PMID: 36087363 PMCID: PMC9444315 | B. Besteher, M. Machnik, M. Troll, A. Toepffer, A. Zerekidze, T. Rocktäschel, C. Heller, Z. Kikinis, St. Brodoehl, K. Finke, P. A, Reuken, N. Opel, A. Stallmach, C. Gaser, M. Walter. |
Electrical impedance tomography (EIT) in a patient suffering from post-Covid syndrome with dyspnea: a Case Report. Diagnostics (Basel), 2022 Sep 21;12(10):2284. doi: 10.3390/diagnostics12102284. PMID: 36291973 PMCID: PMC9599970 | K. Katzer , Y. Gremme, M. Moshmosh Alsabbagh, A. Stallmach, P. Reuken, J.-C. Lewejohann |
Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxford Open Immunology,Immunology, 2022, 3(1), iqac006 und doi 10.1093/oxfimm/iqac006 | S. Haunhorst, W. Bloch, H. Wagner, C. Ellert, K. Krüger, D. C. Vilser, K. Finke, P. Reuken, M. W. Pletz, A. Stallmach, C. Puta |
Disease recurrence in patients with Crohn’s disease after biologic therapy or surgery: a meta-analysis.Int J Colorectal Dis 2022 Oct;37(10):2185-2195. doi: 10.1007/s00384-022-04254-z. Epub 2022 Sep 23. PMID: 36149447 PMCID: PMC9560971 | S. Kneißl, J. Stallhofer, P. Schlattmann, A. Stallmach |
Recurrent disseminated intravascular coagulation in metastatic castration-resistant prostate cancer: a case report. Diagnostics (Basel) 2022 Sep 28;12(10):2342. doi: 10.3390/diagnostics12102342, PMID: 36292031 PMCID: PMC9600388 | B. Giszas , M.Fritzenwanger, M.-O. Grimm, A. Stallmach, P. Reuken |
Integration of ultrasonography training into undergraduate medical education: catch up with professional needs. nsights Imaging. 2022 Sep 24;13(1):150. doi: 10.1186/s13244-022-01296-3, PMID: 36153444 PMCID: PMC9509508 | Teichgräber U, Ingwersen M, Ehlers C, Mentzel HJ, Redies C, Stallmach A, Behringer W, Guntinas-Lichius O. |
Clinical and surgical factors for successful stoma reversal in patients with Crohn's disease-results of a retrospective cohort study. Int Journal of colorectal disease, 2022 Oct;37(10):2237-2244. doi: 10.1007/s00384-022-04262-z. Epub 2022 Oct 3. PMID: 36190548 | Ludewig C, Jacob V, Stallmach A, Bruns T, Teich N |
Critical care hepatology: definitions, incidence, prognosis and role of liver failure in critically ill patients. Crit Care. 2022 Sep 26;26(1):289. doi: 10.1186/s13054-022-04163-1. | Perez Ruiz de Garibay A, Kortgen A, Leonhardt J, Zipprich A, Bauer M |
Evaluation of the definition of hyperdynamic circulation in patients with cirrhosis and ascites: Hepatol Commun. 2022 Dec;6(12):3528-3538. doi: 10.1002/hep4.2102. Epub 2022 Oct 11. PMID: 36221228 PMCID: PMC9701480 | Ripoll C, Ibáñez-Samaniego L, Neumann B, Vaquero J, Greinert R, Bañares R, Zipprich A |
Immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep 2021 Nov 3;4(1):100391. doi: 10.1016/j.jhepr.2021.100391. eCollection 2022 Jan PMID: 34917912 PMCID: PMC8666561 |
Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Große K, Zimmermann HW, Trautwein C, Stallmach A, Bruns T |
Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND randomized trial protocol. Future Oncol. 2022 Apr;18(12):1423-1435. doi: 10.2217/fon-2021-1261. Epub 2022 Jan 27. PMID: 35081747 | Ben Khaled N, Seidensticker M, Ricke J, Mayerle J, Oehrle B, Rössler D, Teupser D, Ehmer U, Bitzer M, Waldschmidt D, Fuchs M, Reuken PA, Lange C, Wege H, Kandulski A, Dechêne A, Venerito A, Berres ML, Luedde T, Kubisch I, Reiter FP, De Toni EN |
A scoping review of regulatory T cell dynamics in convalescent COVID-19 patients - indications for their potential involvement in the development of Long COVID?. Front Immunol. 2022 Dec 13;13:1070994. doi: 10.3389/fimmu.2022.1070994. eCollection 2022. PMID: 36582234 PMCID: PMC9792979 | Haunhorst S, Bloch W, Javelle F, Krüger K, Baumgart S, Druber S, Lemhöfer C, Reuken PA, Stallmach A, Kamradt T, Pletz MW, Puta C |
Sublcinical cognitive impairment in chronic kidney disease is associated to frailty and reduced quality of life. Nephrol Dial Transplant 2022 Nov 2:gfac303. doi: 10.1093/ndt/gfac303. | Greinert R, Greinert D, Eger AL, Ripoll C, Girndt M. |
Reply to "Management of portal hypertension in patients treated with atezolizumab and bevacizumab for hepatocellular carcinoma. J Hepatol 2022 Aug;77(2):567-568. doi: 10.1016/j.jhep.2022.04.029. Epub 2022 May 5. | de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C |
Intestinal Wnt in the transition from physiology to oncology, World J Clin Oncol 2022 Mar 24;13(3):168-185. doi: 10.5306/wjco.v13.i3.168. | Julia Swoboda , Patrick Mittelsdorf , Yuan Chen , Ralf Weiskirchen , Johannes Stallhofer , Silke Schüle , Nikolaus Gassler |
Suppression of MYC by PI3K/AKT/mTOR pathway inhibition in combination with all-trans retinoic acid treatment for therapeutic gain in acute myeloid leukaemia. Br J Haematol2022 Jul;198(2):338-348. doi: 10.1111/bjh.18187. Epub 2022 Apr 25 | Sven Stengel, Kevin R Petrie, Yordan Sbirkov, Clara Stanko, Faezeh Ghazvini Zadegan, Veronica Gil, Rafał Skopek, Paweł Kamiński, Łukasz Szymański, Annamaria Brioli, Arthur Zelent, Tino Schenk |
Global PBC Study Group. Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acid. Aliment Pharmacol Ther. 2022 Nov;56(9):1408-1418. doi: 10.1111/apt.17226. Epub 2022 Sep 22. PMID: 36138566; PMCID: PMC9826062. | de Veer RC, Harms MH, Corpechot C, Thorburn D, Invernizzi P, Janssen HLA, Battezzati PM, Nevens F, Lindor KD, Floreani A, Ponsioen CY, Mayo MJ, Parés A, Mason AL, Kowdley KV, Trivedi PJ, Hirschfield GM, Bruns T, Dalekos GN, Gatselis NK, Verhelst X, Lammers WJ, Hansen BE, van Buuren HR, van der Meer AJ; |
"Antibiotika assoziierte Diarrhoe" coloproctology 2022 44:389-394 | Lange K, Stallmach A |
Publikationen 2021
Balance of macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis. JHEP Rep. 2021 Apr; 3(2): 100221. |
Wirtz TH, Reuken PA, Jansen C, Fischer P, Bergmann I, Backhaus C, Emontzpohl,C, Reißing J, Brandt EF, Koenen MT, Schneider KM, Schierwagen R, Brol MJ, Chang,J, Zimmermann HW, Köse-Vogel N, Eggermann T, Kurth I, Stoppe C, Bucala R, Bernhagen J, Praktiknjo M, Stallmach A, Trautwein C, Trebicka J, Bruns T, Berres ML. |
Ruling out COVID-19 by chest CT at emergency admission to prevent in-hospital spread when prevalence is low – the prospective, observational SCOUT study. Respir Res. 2021 Jan 12;22(1):13 doi:10.1186/s12931-020-01611-w |
Teichgräber U, Malouhi A, Ingwersen M, Neumann R, Reljic M, Deinhardt-Emmer S, Löffler B, Behringer W, Lewejohann JC, Stallmach A, Reuken PA |
Safety of Tofacitinib in the COVID-19 pandemic - enough is not enough. Inflamm Bowel Dis. 2021 Jul 27;27(8):e89. |
Reuken PA, Teich N, Stallmach A |
Kryptosporidiose. |
Reuken PA |
Ein Jahr COVID-19 - Therapiemanagement im Krankenhaus. Ärzteblatt Thüringen 2021(10):18-20 |
Bauer M, Kortgen A, Reuken PA, Stallmach A |
"Ist Post-COVID die 4. Welle in unserem Gesundheitssystem? Erfahrungen aus der Post-COVID Ambulanz am Universitätsklinikum Jena". Ärzteblatt Thüringen 2021(10):21-23 |
Bauer M, Finke K, Heutelbeck A, Mutschke S, Pletz MW, Proquitté H, Quickert S, Reuken PA, Scherag A, Stallmach A, Vilser D, Walter M |
The immunomodulatory receptor VSIG4 is released during spontaneous bacterial peritonitis and predicts short-term mortality. JHEP Rep. 2021 Nov 3;4(1):100391. eCollection Jan 2022. doi: 10.1016/j.jhepr.2021.100391 |
Reißing J, Lutz P, Frissen M, Ibidapo-Obe O, Reuken PA, Wirtz TH, Stengel S, Quickert S, Rooney M. ,Große K, Zimmermann HW, Trautwein C, Stallmach A, Bruns T |
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. Leukemia. 2021 Mar;35(3):920-923. |
Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, Löffler B, Baumgart S, Kamradt T, Bauer M |
Drug-induced Acute Pancreatitis - Anecdotal Evidence versus prospective Evaluation. Gastroenterology. 2021 Jun;160(7):2627-2628 |
Teich N, Bruns T, Stallmach A. |
Post-COVID chronic fatigue is frequent and not only restricted to hospitalized patients. Crit Care Med. 2021 Oct 1;49(10):e1052-e1053 doi: 10.1097/CCM.0000000000005122 |
Reuken PA, Scherag A, Stallmach A |
Greenspace in Childhood: A New Avenue to Prevent Inflammatory Bowel Disease? Am J Gastroenterol 2021 Sep 1;116(9):1964-1965. |
Teich A, Stallmach A, Bruns T |
Microbiota-based markers predictive of development of Clostridioides difficile infection. Nat Comm 2021 Apr 14;12(1):2241. doi: 10.1038/s41467-021-22302-0. |
Berkell M, Mysara M, Xavier BB, van Werkhoven CH, Monsieurs P, Lammens C, Ducher A, Vehreschild MJGT, Goossens H, de Gunzburg J, Bonten MJM, Malhotra-Kumar S; |
A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease. New Engl J Med 2021 Jul 1;385(1):35-45. doi: 10.1056/NEJMoa2032441. |
Schuppan D, Mäki M, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. Collaborator: Grunert PC, Stallhofer J |
Prospective, double-blind diagnostic multicentre study of confocal laser endomicroscopy for wheat sensitivity in patients with irritable bowel syndrome. |
Bojarski C, Tangermann P, Barmeyer C, Buchkremer J, Kiesslich R, Ellrichmann M, Schreiber S, Schmidt C, Stallmach A, Roehle R, Loddenkemper C, Daum S, Siegmund B, Schumann M, Ullrich R. |
Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study). |
Engelmann C, Herber A, Franke A, Bruns T, Reuken PA, Schiefke I, Zipprich A, Zeuzem S, Goeser T, Canbay A, Berg C, Trebicka J, Uschner FE, Chang J, Mueller T, Aehling N, Schmelzle M, Splith K, Lammert F, Lange CM, Sarrazin C, Trautwein C, Manns M, Häussinger D, Pfeiffenberger J, Galle PR, Schmiedeknecht A, Berg T. |
Acceptance of SARS-CoV-2 vaccines by German liver transplant recipients and candidates. Z Gastroenterol. 2021 Dec;59(12):1288-1296 doi:10.1055/a-1649-8568 |
Reuken PA, Albers S, Rauchfuss F, Strnad P, Settmacher U, Trautwein C, Stallmach A, Bruns T |
The use of Faecal Microbiota Transplantation (FMT) in Europe: A Europe-wide survey. Lancet Reg Health Eur. 2021 Jul 19;9:100181. |
Baunwall SMD, Terveer EM, Dahlerup JF, Erikstrup C, Arkkila P, Vehreschild MJ, Ianiro G, Gasbarrini A, Sokol H, Kump PK, Satokari R, De Looze D, Vermeire S, Nakov R, Brezina J, Helms M, Kjeldsen J, Rode AA, Kousgaard SJ, Alric L, Trang-Poisson C, Scanzi J, Link A, Stallmach A, Kupcinskas J, Johnsen PH, Garborg K, Rodríguez ES, Serrander L, Brummer RJ, Galpérine KT, Goldenberg SD, Mullish BH, Williams HR, Iqbal TH, Ponsioen C, Kuijper EJ, Cammarota G, Keller JJ, Hvas CL |
Eine chirurgisch relevante Zusammenfassung des Addendums zu den DGVS-S3-Leitlinien Morbus Crohn und Colitis ulcerosa. Chirurg 92, 30–33 (2021) |
Grunert PC, Dignass A, Kucharzik T, Stallmach A, Sturm A, Schmidt C |
Mineralocorticoid receptor in non-alcoholic fatty liver disease. |
Schreier B, Zipprich A, Uhlenhaut H, Gekle M. |
First things first! Can bacterial infections be considered as decompensating events per se? |
Reichert MC, Ripoll C |
[Cirrhosis]. |
Zipprich A, Ripoll C |
Isolated bacterial infection without decompensation has no impact on survival of compensated patients with cirrhosis. |
Reichert MC, Schneider C, Greinert R, Casper M, Grünhage F, Wienke A, Zipprich A, Lammert F, Ripoll C |
Medikamentöse Therapie chronisch-entzündlicher Darme-rkrankungen – Was muss der Chirurg wissen und perioperativ beachten? [Drug treatment of chronic inflammatory bowel diseases-What must the surgeon know and perioperatively pay attention to?]. Chirurg. 2021 Jan;92(1):3-11. German. doi: 10.1007/s00104-020-01305-5. |
Lange K, Stallmach A |
Appendectomy in childhood-did it save my sibling from getting ulcerative colitis? Int J Colorectal Dis. 2021 Mar;36(3):623-624. doi: 10.1007/s00384-020-03780-y. Epub 2020 Oct 23. |
Teich N, Bruns T, Stallmach A |
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy. J Hepatol. 2021 Apr;74(4):801-810. doi: 10.1016/j.jhep.2020.11.017. Epub 2020 Nov 19. |
Dietz J, Di Maio VC, de Salazar A, Merino D, Vermehren J, Paolucci S, Kremer AE, Lara M, Pardo MR, Zoller H, Degasperi E, Peiffer KH, Sighinolfi L, Téllez F, Graf C, Ghisetti V, Schreiber J, Fernández-Fuertes E, Boglione L, Muñoz-Medina L, Stauber R, Gennari W, Figueruela B, Santos J, Lampertico P, Zeuzem S, Ceccherini-Silberstein F, García F, Sarrazin C |
Post-Test Probability of COVID-19 Using CT. |
Teichgräber T, Behringer W , Stallmach A |
Clinical effectiveness of bidirectional fecal microbiota transfer in the treatment of recurrent Clostridioides difficile infections. |
Bestfater C, Vehreschild MJGT, Stallmach A, Tüffers K, Erhardt A, Frank T, Glück T, Goeser F, Sellge G, Solbach P, Eisenlohr H, Storr M; German Clinical Microbiome Study Group (GCMSG). |
Severe clinical relapse in an immunocompromised host with persistent SARS-CoV-2 infection. |
Reuken PA, Stallmach A, Pletz MW, Brandt C, Andreas N, Hahnfeld S, Löffler B, Baumgart S, Kamradt T, Bauer M. |
Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff. |
Bahrs C, Kimmig A, Weis S, Ankert J, Hagel S, Maschmann J, Stallmach A, Steiner A, Bauer M, Behringer W, Baier M, Kesselmeier M, Richert C, Zepf F, Walter M, Scherag A, Kiehntopf M, Löffler B, Pletz MW |
The COVID-19 Pandemic: Fears and Overprotection in Pediatric Patients with Inflammatory Bowel Disease and Their Families. Pediatr Gastroenterol Hepatol Nutr. 2021 Jan;24(1):65-74. doi: 10.5223/pghn.2021.24.1.65 |
Reinsch S, Stallmach A, Grunert PC |
Nondestructive molecular imaging by Raman spectroscopy vs. marker detection by MALDI IMS for an early diagnosis of HCC Analyst. 2021 Feb 21;146(4):1239-1252. doi: 10.1039/d0an01555e. Epub 2020 Dec 14 |
Kirchberger-Tolstik T, Ryabchykov O , Bocklitz T , Dirsch O , Settmacher U , Popp J , Stallmach A |
Primed circulating monocytes are a source of IL-1β in patients with cirrhosis and ascites. Gut. 2021 Mar;70(3):622-623. doi: 10.1136/gutjnl-2020-321597. Epub 2020 Jun 22 |
Stengel S, Steube A, Köse-Vogel N, Kirchberger-Tolstik T, Deshmukh S, Bruns T |
An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' Perspective. |
Schmidt C, Grunert PC, Stallmach A |
Incidence and predictive biomarkers of Clostridioides difficile infection in hospitalized patients receiving broad-spectrum antibiotics. Nat Commun. 2021 Apr 14;12(1):2240. doi: 10.1038/s41467-021-22269-y. |
van Werkhoven CH, Ducher A, Berkell M, Mysara M, Lammens C, Torre-Cisneros J, Rodríguez-Baño J, Herghea D, Cornely OA, Biehl LM, Bernard L, Dominguez-Luzon MA, Maraki S, Barraud O, Nica M, Jazmati N, Sablier-Gallis F, de Gunzburg J, Mentré F, Malhotra-Kumar S, Bonten MJM, Vehreschild MJGT |
Effect of Originator Infliximab Treatment on Disease-Related Hospitalizations, Work Productivity and Activity Impairment, and Health Resource Utilization in Patients with Crohn's Disease in a Real-Life Setting: Results of a Prospective Multicenter Study in Germany. Inflamm Intest Dis. 2021 Feb;6(1):48-60 |
Teich N, Bläker M, Holtkamp-Endemann F, Jörgensen E, Stallmach A, Hohenberger S. |
Auswirkungen einer SARS-CoV-2-Infektion auf Symptomatik und Therapie chronisch-entzündlicher Darmerkrankungen [Effects of SARS-CoV-2 Infection on Symptoms and Therapy of Inflammatory Bowel Disease]. Z Gastroenterol. 2021 Nov;59(11):1189-1196. German. doi: 10.1055/a-1508-6734. Epub 2021 Jul 16. |
Teich N, Ludewig C, Schmelz R, Bästlein E C, Geißler S, Nagl S, Walldorf J, Krause T, Maaser C, Mohl W, Wedemeyer H H, Bauer T, Büning C, Grunert PC, Hasselblatt P, Hänßchen M, Kahl M, Engelke O,Schubert S, Holler B, Streetz K, von Arnim U, Schmidt K, Stallmach A für die German IBD Study Group |
SARS-CoV-2 vaccination in patients with inflammatory bowel disease – fear and desire. Z Gastroenterol. 2021 Nov;59(11):1189-1196 |
Walldorf J, von Arnim U, Schmelz R, Riesner-Wehner A, Michl A, Grunert PC, Stallmach A, Teich N, Reuken PA |
Computational tissue staining of non-linear multimodal imaging using upervised and unsupervised deep learning. |
Pradhan P, Meyer T, Vieth M, Stallmach A, Waldner M, Schmitt M, Popp J, Bocklitz T. |
Yoghurt-induced Lactobacillus bacteremia in a patient with Crohn's disease on therapy with ustekinumab and concomitant HIV-Infection. Z Gastroenterol. 2021 Apr;59(4):317-320 |
Haziri D, Prechter F, Stallmach A |
T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease. JCC, 2021 Aug 11:jjab147. doi: 10.1093/ecco-jcc/jjab147. |
Reuken PA, Andreas N, Grunert PC, Glöckner S, Kamradt T, Stallmach A |
Recurrent upper gastrointestinal bleeding from isolated gastric varices as primary symptom of myelofibrosis - a case report on combining interventional and pharmacologic treatment options Dig Dis, 2021 Aug 2. doi: 10.1159/000518766. Online ahead of print. |
Giszas B, Weber M, Heidel FH, Reuken PA |
S1-Leitlinie-Post-COVID/Long-COVID [S1 Guideline Post-COVID/Long-COVID]. Pneumologie. 2021,Nov;75(11):869-900 |
Koczulla AR, Ankermann T, Behrends U, Berlit P, Böing S, Brinkmann F, Franke C, Glöckl R, Gogoll C, Hummel T, Kronsbein J, Maibaum T, Peters EMJ, Pfeifer M, Platz T, Pletz M, Pongratz G, Powitz F, Rabe KF, Scheibenbogen C, Stallmach A, Stegbauer M, Wagner HO, Waller C, Wirtz H, Zeiher A, Zwick RH |
Long-/Post-COVID – Wenn das Virus Spuren hinterlässt - eine klinische Übersicht für Behandelnde, basierend auf der aktuellen S1 Leitlinie. Deutsches Ärzteblatt Int, 2021, 118(39):A-1762/B-1459 |
Koczulla AR, Glöckl R, Peters EMJ, Rabe KF, Stallmach A, Gogoll C |
Clinical characteristics and outcome of patients with enterococcal liver abscess. Scientific Reports 2021 Nov 15;11(1):22265. doi:10.1038/s41598-021-01620-9. |
Große K, Ohm D, Würstle S, Brozat JF, Schmid RM, Trautwein C, Stallmach A, Bruns T, Reuken PA |
Results from the German registry for refractory celiac disease. |
Weber M, Wolf N, Branchi F, Tangermann P, Itzlinger A, Poralla L, Preiß JC, Grunert P, Daum S, Siegmund B, Stallmach A, Schumann M |
The impact of specific cytokine directed treatment on severe COVID-19. Leukemia, 2021 Dec;35(12):3613-3615. doi: |
Reuken PA, Rüthrich MM, Hochhaus A, Hammersen J, Bauer M, La Rosée P, La Rosée F, Stallmach A |
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure, J Hepatol. 2021 Feb;74(2):330-339. doi: 10.1016/j.jhep.2020.07.046. Epub 2020 Aug 8. |
Wong F, Piano S, Singh V, Bartoletti M, Maiwall R, Alessandria C, Fernandez J, Soares EC, Kim DJ, Kim SE, Marino M, Vorobioff J, Barea RCR, Merli M, Elkrief L, Vargas V, Krag A, Singh SP, Lesmana LA, Toledo C, Marciano S, Verhelst X, Intagliata N, Rabinowich L, Colombato L, Kim SG, Gerbes A, Durand F, Roblero JP, Bruns T, Yoon EL, Girala M, Pyrsopoulos NT, Kim TH, Yim SY, Juanola A, Gadano A, Angeli P |
A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis, Am J Gastroenterol. 2021 Jul 1;116(7):1514-1522. doi: 10.14309/ajg.0000000000001285 |
Goet JC, Murillo Perez CF, Harms MH, Floreani A, Cazzagon N, Bruns T, Prechter F, Dalekos GN, Verhelst X, Gatselis NK, Lindor KD, Lammers WJ, Gulamhusein A, Reig A, Carbone M, Nevens F, Hirschfield GM, van der Meer AJ, van Buuren HR, Hansen BE, Parés A |
Reply to: "G-CSF in acute-on-chronic liver failure - Art of 'patient selection' is paramount!", J Hepatol. 2022 Feb;76(2):473-475. doi: 10.1016/j.jhep.2021.10.019. Epub 2021 Oct 29. |
Engelmann C, Bruns T, Berg T |
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool, Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1S Suppl 1):e266-e273. doi: 10.1097/MEG.0000000000002029. |
Murillo Perez CF, Gulamhusein A, Carbone M, Trivedi PJ, van der Meer AJ, Corpechot C, Battezzati PM, Lammers WJ, Cazzagon N, Floreani A, Parés A, Nevens F, Lleo A, Mayo MJ, Kowdley KV, Ponsioen CY, Dalekos GN, Gatselis NK, Thorburn D, Mason AL, Janssen H, Verhelst X, Bruns T, Lindor KD, Chazouillères O, Invernizzi P, Hansen BE, Hirschfield GM |
Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled |
Peyrin-Biroulet L, Hart A, Bossuyt P, Long M, Allez M, Juillerat P, Armuzzi A, Loftus EV Jr, Ostad-Saffari E, Scalori A, Oh YS, Tole S, Chai A, Pulley J, Lacey S, Sandborn WJ; |